Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target
Ryan M. Young(Denver Health Medical Center), Yosef Refaeli(University of Colorado Denver)
Cited by 117
Related Papers
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Oncogenically active MYD88 mutations in human lymphoma
|Nature|2010|1.5k
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications
|Cancer Cell|2020|1.1k
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
|Nature Medicine|2015|1.1k